Patient guide · 03
Understanding OnKommon Twin.
What Twin is
Cancer care often involves many separate reports — scans, blood tests, biopsies, molecular tests. Twin brings the available pieces together into a structured picture, sometimes called a “digital twin” of the cancer.
It is examined through 21 different analytical lenses — for example, whether a change is inherited, whether it is linked to a treatment, or whether there are clinical trials worth looking at. Your oncologist receives one structured report with five parts.
What Twin is not
Six months, then next steps
Twin isn't a one-off report. After the first picture is built, new findings and evidence are reviewed for six months. At the end, your oncologist reviews everything and decides on the next step — which may be one of three follow-on “Twin tracks”, whose details are being finalised.
01 · Baseline — Day 0
Integrate the data. Build the Twin.
02 · During months 0–6
Review new findings inside the workflow.
03 · End of month 6
Review the evidence. Set the next pathway.
Who is involved
Your oncologist
Chooses the test, reviews and signs every report, and makes every treatment decision with you.
KPCIRC's tumour board
A team of specialists who discuss the findings and their implications.
OnKommon Twin
Organises the information and evidence for your oncologist to review.
And AVATAR?
OnKommon AVATAR is a separate research programme for some solid tumours. It studies selected tumour changes in fruit-fly models. Results from flies are not proof that a drug will work for a person, and AVATAR is not a way to choose your treatment. If research participation is ever appropriate, it follows an approved protocol with its own consent.